Company / Accounts Receivable
Henry Schein Accounts Receivable History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.7B
FY2025
5-year range
$1.4B / $1.7B
FY2021-FY2025
Trend
+11.4%
vs FY2024
Sector context
#17 of 138
Health Care
What the data says
Henry Schein's accounts receivable of $1.7B is higher than 88% of companies in the Health Care sector (FY2025). Accounts Receivable has fluctuated over the past 10 years, ranging from $1.2B in FY2018 to $1.7B in FY2025.
Based on SEC 10-K filings.
$1.7B in FY2025 with a 5-year CAGR of +3.0%. Top quartile in the Health Care sector.
Improved from $1.4B to $1.7B over the past 2 years.
Health Care sector context is included.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- +4.6%
- 5-Year CAGR
- +3.0%
- 10-Year CAGR
- -
Sector benchmark
Top 12% in Health CareTop 12% of 138This company $1.7B Sector average $1.3B
▼
+25.0% above sector average
Key checks
Key Insights
- 5-year CAGR of +3.0%, indicating consistent growth.
- In FY2025, accounts receivable increased 11.4% year-over-year.
- Ranks #17 out of 138 companies in the Health Care sector.
- Lowest accounts receivable in the period was in FY2018.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.7B | +11.4% |
| FY2024 | $1.5B | +2.8% |
| FY2023 | $1.4B | +0.0% |
| FY2022 | $1.4B | -0.7% |
| FY2021 | $1.5B | +1.9% |
| FY2020 | $1.4B | +14.3% |
| FY2019 | $1.2B | +6.6% |
| FY2018 | $1.2B | -23.2% |
| FY2017 | $1.5B | +21.4% |
| FY2016 | $1.3B | +2.0% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026